Skip to main content
. 2022 Aug 3;2022:5734876. doi: 10.1155/2022/5734876

Table 5.

Comparison of cardiovascular adverse events 3 months after surgery among the three groups (n(%)).

Group Heart failure Ventricular fibrillation Death Total incidence of cardiovascular adverse events
Group A (n = 28) 3 (10.71) 0 (0.00) 0 (0.00) 3 (10.71)c
Group B (n = 28) 4 (14.29) 2 (7.14) 1 (3.57) 7 (25.00)c
Group C (n = 28) 9 (32.14) 3 (10.71) 3 (10.71) 15 (53.57)

aSame group comparison before treatment (P < 0.05). bComparison with group B (P < 0.05). cComparison with group C (P < 0.05).